➡️ COVID Vaccination will be administered to frontline workers from February 6 in Odisha.
➡️ Union Transport Minister Nitin Gadkari holds discussion with Odisha Chief Minister Naveen Patnaik.
➡️ 300 km Paradip-Barbil Road to be converted into 8-Lane Highway, informs Union Minister Dharmendra Pradhan.
➡️ Gopalpur-Digha Coastal Highway project to be extended up to Satpada.
➡️ Odisha Govt begins process for refund of Money to small Chit Fund depositors in Balasore.
➡️ Odisha records 25.30% growth in collection of gross GST in January this year with collection of Rs 3,137.45 crore.
➡️ Bhubaneswar reports 8 Covid-19 local cases and 10 recoveries in last 24 hours; taking the total positive cases to 31885 in the Capital City.
➡️ 138 Covid-19 patients have recovered from the disease in Odisha in the last 24 hours. The total recovered cases of Odisha now stand at 332377.
➡️ No Covid-19 death in Odisha for a week. Nabarangapur District is Corona Free for the time being.
➡️ National Testing Agency will conduct UGC-NET exam for Junior Research Fellowship and eligibility for Assistant Professor in from May 2.
➡️ CBSE Class 10, 12 Board Exams are scheduled to be held from May 4 to June 10.
➡️ First phase of census, updation of NPR have been postponed due to COVID-19: Home Ministry
➡️ AAP MP Sanjay Singh has given Suspension of Business notice in Rajya Sabha over ongoing farmers agitation.
➡️ The total number of healthcare workers vaccinated against COVID-19 has crossed 41 lakhs today: Union Health Ministry.
➡️ Maharashtra: Fire reorted at a studio in Goregaon, Mumbai. No injuries reported so far.
➡️ Suspension of internet services extended till 5 pm tomorrow in 7 districts of Haryana.
➡️ Flipkart, Amazon to pay 2% extra Tax now.
➡️ India vs England: The first Test between India and England will be played behind closed doors while the second Test will have 50% crowd.
➡️ Scientists fear COVID-19 UK variant has mutated again.
➡️Republicans urge Joe Biden to scale back $1.9 trillion COVID-19 relief plan.
➡️Sputnik V Covid vaccine 91.6% effective in Phase-III trial.